Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (1207)	2/14/2000 9:52:00 PM
From: William Strop	Read Replies (1) \| Respond to of 1972

Scott, Thanks for the conference schedules. I agree that the May Oncology Conference may be the best as far as news. Maybe some Allovectin-7 and/or Leuvectin news. Hopefully by then the Malaria vaccine will be in Phase II. My educated guess is they Vical has a very good rapport with the FDA because as we long time shareholders know, they don't hype this Company. Vical seems to do what they say they will do & I would hope the FDA likes that better than hype. Bill